Deals Rumor Mill: Amgen, Wal-Mart, Cinven

Law360, New York (August 7, 2013, 4:30 PM EDT) -- Biotech giant Amgen Inc. is closing in on a much-anticipated $9.5 billion buyout of cancer treatment provider Onyx Pharmaceuticals Inc. and could announce finalized terms within the next week, according to a Wednesday report from Reuters. The dealmaking scene has buzzed with speculation over whether — and when — the two could hammer out a sale agreement, sure to be one of the largest the drugmaking sector has seen this year. Onyx spurned a separate bid from Amgen in late June, but has suggested it would...
To view the full article, register now.